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Abstract Many members of the Inhibitor of Apoptosis (IAP)
family inhibit cell death and existing data suggest at least two
mechanisms of action. Drosophila IAPs (D-IAP1 and D-IAP2)
and a baculovirus-derived IAP, Op-IAP, physically interact with
and inhibit the anti-apoptotic activity of Reaper, HID, and Grim,
three genetically defined inducers of apoptosis in Drosophila,
while human IAPs, c-IAP1, c-IAP2, and X-IAP interact with a
number of different proteins including specific members of the
caspase family of cysteine proteases which are crucial in the
execution of cell death. We have examined whether insect-active
IAPs can inhibit apoptosis induced by selected caspases,
Drosophila drICE, Sf-caspase-1, and mammalian caspase-3, in
insect SF-21 cells. D-IAP1 inhibited apoptosis induced by the
active forms of all three caspases tested and physically interacted
with the active, but not the proform of drICE. MIHA, the mouse
homolog of X-IAP and an effective inhibitor of caspase-3, also
interacted with and blocked apoptosis induced by active drICE
but was relatively ineffective in blocking Sf-caspase-1. Op-IAP
and D-IAP2 were unable to inhibit effectively any of the active
caspases tested and failed to interact with drICE. The
Drosophila IAPs and Op-IAP, but not MIHA, blocked HID-
initiated activation of pro-drICE. We conclude that D-IAP1 is
capable of inhibiting the activation of drICE as well as inhibiting
apoptosis induced by the active form of drICE. In contrast, D-
IAP2 and Op-IAP are more limited in their inhibitory targets
and may be limited to inhibiting the activation of caspases.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The evolutionarily conserved process of apoptosis plays an
important role in removing cells during development and in
maintaining tissue homeostasis, but the dysregulation of
apoptosis, leading to too much or too little cell death, can
contribute to a number of diseases including neurodegenera-
tive disorders and cancer [1]. Designing therapeutic solutions
requires that we understand the interplay between positive
and negative regulators of the apoptotic program.
Members of the inhibitor of apoptosis (iap) gene family act
as antagonists of cell death in metazoans ranging from Dro-
sophila to humans [2]. IAPs were ¢rst discovered in baculovi-
ruses by their ability to block apoptosis induced during viral
infection [3]. IAPs have since been found in nematodes, in-
sects, birds, and mammals [4^11], underscoring the recurrent
theme that the components of the cell death program have
been conserved throughout metazoan radiation. Members of
the IAP family are characterized by the presence of at least
one and usually two or three tandem baculovirus IAP repeat
(BIR) motifs located in the amino-terminal and central por-
tions of the protein [12], and most of them have a carboxy-
terminal RING ¢nger motif. The ability of IAPs of animal
origin to regulate cell death was genetically established in
Drosophila where deletion of the chromosomal region encod-
ing Drosophila IAP1 (D-IAP1) was found to enhance cell
death induced by expression of the pro-apoptotic gene reaper
[13]. Overexpression of either D-IAP1 or D-IAP2 in the Dro-
sophila eye suppresses normal cell death induced by expression
of the pro-apoptotic genes reaper or hid [13]. Reaper, hid, and
another Drosophila pro-apoptotic gene, grim, are all located in
the 75C1^2 chromosomal region, share a short stretch of se-
quence similarity at their N-termini and have been genetically
identi¢ed as inducers of apoptosis in Drosophila embryos [14^
16]. The precise mechanism by which these three proteins
interact with the cell death machinery is not understood,
but they must induce apoptosis through the activation of cas-
pases, since p35, a known caspase (cysteine-dependent aspar-
tate-speci¢c proteases) inhibitor [17], can block cell death in-
duced by the expression of Reaper, HID, or Grim [15,16,18^
25].
The activation of caspases is a crucial step in apoptotic
signaling and is required to execute the cell death program
[26]. Caspases are activated by cleavage at internal aspartate
residues. Two of the proteolytic fragments form heterodimers
which assemble to generate the mature, active enzyme that
subsequently uses its precursor form and other caspases as
substrates [27]. The cascade of caspase activations ampli¢es
the death signal, thereby committing the cell to apoptosis.
drICE is one of three known caspases in Drosophila mela-
nogaster [25]. Transcripts of drICE can be detected through-
out £y development [25]. Overexpression of Reaper triggers
the activation of endogenous drICE and immunodepletion
studies suggest that drICE is essential for apoptosis in Droso-
phila S2 cells [28].
The mechanisms of IAP action are just beginning to be
characterized, but since IAPs block apoptosis induced by a
variety of stimuli, IAPs must target a central point or multiple
points within apoptotic pathways [29]. The anti-apoptotic ba-
culovirus IAPs (e.g. Op-IAP) block the activation of an en-
dogenous caspase, Sf-caspase-1, which is normally activated
during baculovirus infection of SF-21 insect cells and blocked
by the caspases inhibitor p35 [30^32]. Unlike baculovirus p35
which is able to inhibit active Sf-caspase-1, the baculovirus
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IAPs are unable to block apoptosis induced by activated Sf-
caspase-1 or by mammalian caspase-3 [30]. Although the
mechanism by which Sf-caspase-1 is activated during infection
is not known, Op-IAP as well as Drosophila IAPs (D-IAP1
and D-IAP2), physically interact with and block apoptosis
induced by Reaper, HID, and Grim [24,33]. Baculovirus
Op-IAP also physically interacts with and blocks apoptosis
induced by Doom, a protein identi¢ed only in Drosophila to
date [34].
Mammalian IAPs interact with a number of di¡erent pro-
teins involved in apoptosis including caspases. Mammalian c-
IAP1 and c-IAP2 are induced by NF-UB and, in conjunction
with TRAF-1 and TRAF-2, are recruited to the tumor ne-
crosis factor receptor (TNFR) and inhibit apoptosis induced
by TNF-K [35^37]. The action of IAPs at proximal points in
apoptotic signaling pathways is also suggested by the obser-
vation that c-IAP1 and c-IAP2 can interact with Reaper and
Grim and block apoptosis initiated by their overexpression in
mammalian cells [38]. However, direct involvement of mam-
malian IAPs in caspase regulation is supported by the obser-
vation that c-IAP1, c-IAP2 and X-IAP (hILP) bind to and
inhibit the activated forms of caspase-3 and -7 and are also
capable of binding to and inhibiting the activation of the pro-
form of caspase-9 [39^42]. To date, no such caspase interac-
tion or inhibition has been described for insect-active IAPs.
In this study, we examined the ability of selected IAPs to
block apoptosis initiated by active caspases. We found that
both D-IAP1 and the mouse X-IAP homolog, MIHA, but not
D-IAP2 and Op-IAP, block apoptosis induced by expression
of active drICE and caspase-3. D-IAP1 also e⁄ciently sup-
pressed apoptosis induced by active Sf-caspase-1, unlike the
other IAPs tested. D-IAP1 and MIHA failed to bind the pro-
form of drICE, but consistent with inhibition studies, D-IAP1
and MIHA physically interacted with activated drICE. HID
initiated the processing of drICE, and this activity was
blocked by Op-IAP and the Drosophila IAPs, but not by
MIHA. Thus, our results further de¢ne the apoptotic pathway
of Drosophila and establish caspase inhibition as an evolutio-
narily conserved mechanism by which at least some IAPs
silence cell death signaling.
2. Materials and methods
2.1. Cell line and plasmid constructs
Spodoptera frugiperda (Lepidoptera: Noctuidae) IPLB-SF-21 (SF-
21) cells were maintained at 27‡C in TC-100 medium (Gibco BRL,
Gaithersburg, MD) supplemented with 10% fetal bovine serum (Inter-
gen, Purchase, NY) and 0.26% tryptose broth as previously described
[43]. All plasmids used were derived from pHSP70PLVI+CAT, a
plasmid expressing the cat gene under the control of the Drosophila
hsp70 promoter [29]. Plasmids expressing non-tagged Op-iap, D-iap1,
D-iap2, p35, cat, Sf-caspase-1(p19), caspase-3(p17) or hid, Flag-tagged
Op-iap, hid, or cat, and HA.11-tagged (Epi) Op-iap, D-iap1, D-iap1-
BIRs, D-iap1-RING, D-iap2, Sf-caspase-1-pro, Sf-caspase-1(p11),
caspase-3(p12) or cat were all described previously [23,24,29,30,33].
Plasmids encoding the epitope-tagged and untagged versions of
miha were constructed from pHSP70PLVI+CAT, pHSEpiOpIAPVI+,
or pHSFlagD-IAP1VI+ by replacing cat, Op-iap, or D-iap1 with the
open reading frame of miha. The plasmid pHSdrICE-EpiHisVI+ con-
tains the sequence encoding drICE fused to a carboxy-terminal
HA.11-epitope tag and six consecutive histidines. The plasmid
pHSdrICE(80^230)VI+ encodes amino acids 80^230 of drICE which
corresponds to the large (p19) subunit of the active enzyme, and
pHSdrICE(230^339)-EpiHisVI+ encodes the carboxy-terminal amino
acids 230^339 of drICE fused to six histidines and the HA.11-epitope
tag. This portion of drICE includes what probably constitutes
the small subunit (p11) of the active form of drICE as well as an
additional 13 amino acid residues. When transfected alone, this plas-
mid expressed a 12 kDa product, and when cotransfected with
pHSdrICE(80^230)VI+, an 11 kDa product is generated from the
12 kDa product. For simplicity we refer to this plasmid as encoding
the small (p11) subunit of drICE. The plasmid pHSP70PLVI+EpiD-
IAP1-BIRs was digested with EcoRV and PstI and the smallest frag-
ments were subcloned into the PspAI and PstI sites of pHSEpiO-
pIAPVI+ to generate pHSP70PLVI+EpiDIAP1BIR2 which expresses
amino acids 97^342 of D-IAP1. The sequence encompassing the BIR1
of D-IAP1 (amino acids 2^186) were subcloned into pHSEpiOpBIR-
VI+ by replacing the Op-iap sequence to generate pHSP70PLVI+
EpiD-IAP1-BIR1. The amino acid numbers given for positions within
D-IAP1 begin with the second methionine [44] of the published se-
quence [13].
2.2. Viability assays
SF-21 cells plated at a density of 0.5U106 per 35 mm dish were
transfected with recombinant plasmids. At 18 h post transfection, cells
were heat shocked, and 8 h following heat shock, the medium was
aspirated o¡ each plate and replaced with 500 Wl of phosphate bu¡-
ered saline (PBS; pH 6.2) containing 0.04% trypan blue. Viable intact
cells were counted from four di¡erent ¢elds of view at 400U magni-
¢cation. The percent of non-viable cells was calculated as the di¡er-
ence between the number of viable cells in the cat-only transfected
control (100%) and the number of viable cells in the test transfected
cells. Each datum plotted represents three experiments, þ standard
deviation.
2.3. Immunoprecipitation and immunoblot analysis
Coimmunoprecipitations were performed essentially as described
[24,33] except that the plasmid encoding p35 was included only where
speci¢cally indicated and that cells were harvested at 10 h following
heat shock. At 4 h following induction of gene expression by heat
shock, the medium of designated samples was replaced with medium
containing actinomycin D at a concentration of 1 Wg/ml.
3. Results and discussion
3.1. D-IAP1 inhibits apoptosis induced by the active form of
drICE, caspase-3, and Sf-caspase-1
Preliminary studies showed that transfection of SF-21 cells
with a plasmid expressing the proform of drICE did not in-
duce apoptosis, but cotransfection with plasmids expressing
the two subunits of active drICE, p19 and p11, induced apop-
tosis in approximately 50% of the cells (data not shown). To
determine whether drICE-induced apoptosis can be blocked
by members of the IAP family, we cotransfected plasmids
expressing the two subunits of drICE along with plasmids
expressing D-IAP1, D-IAP2, MIHA, Op-IAP, or the control
chloramphenicol acetyl transferase (CAT) gene. Compared to
a cat-only transfected control, drICE induced apoptosis in
46% of the cells (Fig. 1A). D-IAP2 and Op-IAP exhibited
little or no ability to protect against drICE-induced apoptosis
(Fig. 1A) even though they e¡ectively block Reaper-induced
apoptosis under identical conditions [23]. However, D-IAP1
reduced cell death by four-fold (Fig. 1A). MIHA was not as
e⁄cient as D-IAP1, but more than a two-fold decrease in
apoptosis was observed (Fig. 1A). As previously reported
[25], p35 potently blocked drICE (Fig. 1A). Thus, di¡erent
IAPs display di¡ering abilities to protect against drICE-in-
duced apoptosis, and both MIHA and D-IAP1 can inhibit
apoptosis induced by the active form of this caspase.
We have previously shown that baculovirus IAPs do not
block apoptosis induced by the active form of mammalian
caspase-3 or Sf-caspase-1 in SF-21 cells [30], but it was un-
known whether the cellular IAPs D-IAP1, D-IAP2, and
MIHA behave like the viral IAPs; therefore, we cotransfected
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plasmids expressing the subunits of caspase-3 or Sf-caspase-1
with CAT, D-IAP1, D-IAP2, MIHA, and Op-IAP. D-IAP1
and MIHA blocked caspase-3-induced apoptosis almost as
completely as p35, but as observed for drICE-induced apop-
tosis, D-IAP2 and Op-IAP had little e¡ect (Fig. 1B). D-IAP1
also suppressed apoptosis induced by active Sf-caspase-1,
whereas Op-IAP and D-IAP2 did not (Fig. 1C). MIHA,
which blocked both drICE and caspase-3, only slightly dimin-
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Fig. 1. D-IAP1 inhibits active drICE, caspase-3, and Sf-caspase-1. SF-21 cells were cotransfected with 1.25 Wg of each plasmid expressing the
subunits of active drICE (p19+p11) (A), caspase-3 (p17+p12) (B), or Sf-caspase-1 (p19+p12) (C) and 2.5 Wg of plasmids expressing cat, D-iap1,
D-iap2, miha, Op-iap, or p35. D: SF-21 cells were cotransfected with 0.5 Wg of each plasmid expressing the subunits of active drICE and 4 Wg
of plasmids expressing the HA.11 epitope-tagged D-IAP1 constructs Epi-D-IAP1 (amino acids 2^401), Epi-D-IAP1-BIRs (2^342), Epi-D-IAP1-
BIR1 (2^186), Epi-D-IAP1-BIR2 (97^342), or Epi-D-IAP1-RING (275^401). Cell viability was determined by trypan blue exclusion 8 h follow-
ing induction of gene expression by heat shocking the cells for 30 min at 42‡C. The results shown are relative to the viability of cat-only trans-
fected cells (100%) and represent at least three independent experiments for each cotransfected combination. Standard deviations are indicated
by error bars.
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ished cell death initiated by Sf-caspase-1. Thus, the ability of
an IAP to block active caspases depends on the IAP as well as
the caspase. Although the viral Op-IAP is unable to block
apoptosis induced by any of the active caspases tested, D-
IAP1 is a potent inhibitor of active caspases from dipteran,
lepidopteran, and mammalian sources.
To better de¢ne the region of D-IAP1 responsible for in-
hibiting drICE, a series of N-terminally HA.11 epitope-tagged
(Epi) D-IAP1 truncations were tested for anti-apoptotic func-
tion. Epi-D-IAP1-RING, which contained the RING ¢nger
and most of the linker region between the BIRs and RING
¢nger, did not block apoptosis induced by drICE, but the N-
terminal region of D-IAP1 containing BIRs 1 and 2 (Epi-D-
IAP1-BIRs) retained the ability to suppress cell death (Fig.
1D). Epi-D-IAP1-BIR1, which expressed BIR1 and most of
the linker region between the two BIRs, was unable to block
drICE, but a construct expressing BIR2 and the £anking
spacer regions (Epi-D-IAP1-BIR2) retained the ability to
block apoptosis (Fig. 1D). Thus, the region encompassing
the BIR2 of D-IAP1 is necessary and su⁄cient for blocking
drICE-induced apoptosis. A single BIR of X-IAP is also
known to possess anti-apoptotic activity [41].
3.2. D-IAP1 physically interacts with active drICE
Because D-IAP1 protected SF-21 cells from drICE-induced
cell death and because mammalian IAPs are known to physi-
cally interact with and inhibit caspases, we investigated the
possibility that D-IAP1 physically associates with drICE.
We transiently coexpressed Flag-tagged versions of CAT, D-
IAP1, D-IAP2, MIHA, or Op-IAP with the carboxy-terminal
HA-tagged drICE (drICE-pro-Epi) and determined if anti-
Flag antibody could coprecipitate the HA-tagged drICE pro-
tein. In the absence of an apoptotic stimulus, drICE remained
primarily in its proform (drICE-pro-Epi; Fig. 2, middle panel,
lanes 1, 3, 5, 7, and 9) and failed to coprecipitate with the
Flag-CAT negative control or any of the Flag-tagged IAPs
(Fig. 2, top panel, lanes 1, 3, 5, 7, and 9) even though all Flag-
tagged constructs were expressed (Fig. 2, bottom panel, lanes
1, 3, 5, 7, 9). Thus, none of the IAPs tested appear to interact
e⁄ciently with the proform of drICE.
Since mammalian IAPs interact with the active but not the
proform of some caspases, we also investigated the possibility
that IAPs interact with the active form of drICE. Although
we did not detect interactions when IAPs were cotransfected
with the two drICE subunits (data not shown); an interaction
was observed when the proform of drICE was activated by
addition of actinomycin D, a potent inducer of apoptosis in
SF-21 cells [29,44]. The processing of drICE, as evidenced by
the presence of the p11-Epi subunit (Fig. 2, middle panel,
lanes 2, 4, 6, 8, and 10), was observed in all actinomycin D
treated samples including those expressing Flag-D-IAP1 and
Flag-Op-IAP. Although D-IAP1 and Op-IAP inhibit actino-
mycin D-induced apoptosis in SF-21 cells [44], the Flag-
tagged versions of these IAPs are only partially e¡ective at
inhibiting this potent stimulus and extensive apoptosis was
observed in all treated samples (data not shown). Flag-D-
IAP1 strongly coprecipitated the p11-Epi subunit, indicating
that D-IAP1 physically interacts with active drICE (Fig. 2,
top panel, lane 4). MIHA also coprecipitated the p11 subunit
of drICE (Fig. 2, top panel, lane 8). The drICE-p11 interac-
tion with MIHA was less pronounced than with D-IAP1
probably because MIHA expression levels were not as high
as for D-IAP1 (Fig. 2, bottom panel, compare lanes 4 and 8).
Thus, the two IAPs which are able to e¡ectively block drICE-
induced apoptosis also physically interacted with the active,
not the proform, of drICE in SF-21 cells. Op-IAP and D-
IAP2, which were ine¡ective in blocking drICE-induced apop-
tosis, and the control CAT failed to interact with the proform
or the active form of drICE (Fig. 2, top panel, lanes 2, 6, and
10).
3.3. Drosophila and baculovirus IAPs block HID-induced
processing of drICE
We have previously demonstrated that HID-induces apop-
tosis in SF-21 cells and that Op-IAP as well as D-IAP1 and
D-IAP2 are able to block HID-induced apoptosis [24]. To
determine if drICE is processed into its active form during
HID-induced apoptosis, we cotransfected SF-21 cells with
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Fig. 2. D-IAP1 physically interacts with active drICE. SF-21 cells
were transiently transfected with plasmids expressing C-terminally
HA.11 epitope-tagged (Epi) drICE and the indicated Flag epitope-
tagged constructs. At 4 h following heat shock, the medium of the
indicated samples was replaced with medium containing actinomycin
D (Act D+). Ten hours following heat shock, aliquots of cell lysates
were incubated overnight with M2 anti-Flag monoclonal antibody
resin. Coprecipitated HA.11 epitope-tagged constructs were detected
by immunoblot analysis with the rabbit anti-HA.11 polyclonal anti-
serum (IP). Expression of HA.11-tagged (mHA Ab) and Flag-tagged
proteins (Flag Ab) were con¢rmed. Molecular mass markers (in
kDa) are shown on the left.
W.J. Kaiser et al./FEBS Letters 440 (1998) 243^248246
plasmids expressing drICE-pro-Epi and either CAT (Fig. 3A,
lanes 1^3) or HID (Fig. 3A, lanes 4^6). Following induction
of gene expression, samples were collected at 1h intervals.
Immunoblot analysis revealed that HID initiates drICE-pro-
Epi processing as indicated by the appearance of the small
active p11-Epi subunit (Fig. 3A). The p11-Epi subunit was
not detected in samples cotransfected with CAT and drICE-
pro-Epi. To determine the e¡ect of IAPs on HID-activation of
drICE, we cotransfected plasmids expressing drICE-pro-Epi
and HID, with plasmids expressing D-IAP1, D-IAP2,
MIHA, or Op-IAP. Proteolytic processing was not observed
in samples cotransfected with the D-IAP1, D-IAP2, or Op-
IAP (Fig. 3A, lanes 7^12 and 16^18), but MIHA did not
block processing (Fig. 3A, lanes 13^15).
All IAPs tested were able to reduce the level of apoptosis
induced by HID (Fig. 3B), but MIHA was not as e¡ective as
the other IAPs. The presence of drICE cleavage products
observed in cotransfections of HID and MIHA correlates
with the high levels of apoptosis (Fig. 3). D-IAP1, D-IAP2,
and Op-IAP all interact with HID [24], but we did not detect
interaction between MIHA and HID (data not shown). Thus,
there is a correlation between the ability of the IAPs to bind
to HID, to block HID-induced apoptosis, and to block drICE
activation. Although it is possible that D-IAP1, D-IAP2, and
Op-IAP act by binding to the caspase(s) which may activate
drICE in SF-21 cells, only D-IAP1 is capable of blocking Sf-
Caspase-1. Thus D-IAP2 and Op-IAP must either block HID-
induced apoptosis by their interaction with another Sf-caspase
or with HID itself. Until we know more about how HID
initiates caspase activation, it will be di⁄cult to distinguish
between these two possible mechanisms. The mechanisms may
also be related if there is competition between HID and active
caspases for D-IAP1 binding; through competitive binding to
IAPs, the presence of pro-apoptotic proteins could result in
the release of active caspases from D-IAP1 inhibition.
It is likely that the interaction between D-IAP1 and drICE
results in inhibition of drICE proteolytic activity although out
data are restricted to showing that D-IAP1 can inhibit drICE-
induced apoptosis in vivo. drICE may activate apoptosis in
SF-21 cells directly or by activation of another caspase such
as Sf-caspase-1. The striking correlation between the ability of
IAPs to bind drICE and inhibit drICE-induced apoptosis sug-
gests that IAP interaction results in inhibition of drICE pro-
teolysis. Although Op-IAP is an e¡ective inhibitor of a variety
of apoptotic inducers, it fails to interact with or block drICE-
induced apoptosis in SF-21 cells.
The observation that D-IAP1 interacts with caspases as well
as apoptotic inducers such as Reaper, HID and Grim, places
D-IAP1 in a potentially pivotal position to regulate apoptosis.
If a signi¢cant portion of caspases are present in the cell in
their mature form but are bound to and inhibited by D-IAP1,
then expression of an inducer that competitively binds D-
IAP1 would be su⁄cient to release caspases from inhibition
and initiate a proteolytic cascade. The role of other IAPs such
as D-IAP2 and Op-IAP, which do not appear to interact with
and block caspases, would be to serve as bu¡ers, competing
for D-IAP1 binding. This model would provide a mechanism
for Reaper, HID, and Grim action in which D-IAP1 inhib-
ition of caspase activity plays a central, decisive role in gov-
erning cell death. It remains possible, however, that inducers
such as Reaper, HID, and Grim have a more direct role in
caspase activation. In this case, the fact that D-IAP1 also
binds caspases can be viewed as one more pro-apoptotic pro-
tein that IAPs are able to interact with in their role as sensors
and enumerators of intracellular apoptotic inducing signals.
The emerging picture is that IAPs are broadly functional
inhibitors of apoptosis and that their levels relative to that of
apoptotic inducers, determines cell survival or cell death (see
Fig. 4). Thus, the level of IAPs in a cell acts as an apopstat:
when IAP levels are high, caspases are inhibited, and the cell
is relatively resistant to apoptosis, but when the levels of IAP-
interacting inducers rise above the level of available unbound
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Fig. 3. D-IAP1, D-IAP2, and Op-IAP block HID-initiated processing of drICE. A: SF-21 cells were transfected with plasmids expressing
drICE-pro-Epi and one of the following: CAT, D-IAP1, D-IAP2, MIHA, or Op-IAP. HID was also cotransfected in lanes 4^18. Plasmid con-
centrations were balanced for all samples with addition of CAT-expressing plasmid. Cells were collected and lysed at the indicated times follow-
ing heat shock. Immunoblot analysis of C-terminally HA.11-tagged drICE using anti-HA.11 monoclonal antibody revealed the drICE zymogen
(drICE-pro-Epi) and processed p11 (p11-Epi) subunit. B: SF-21 cells were transfected with plasmids expressing the indicated proteins. Plasmid
concentrations were balanced for all samples with addition of CAT-expressing plasmid. Cell viability was determined by trypan blue exclusion
8 h following induction of gene expression. The results shown are relative to the viability of cat-only transfected cells (100%) and represent at
least three independent experiments for each cotransfected combination. Standard deviations are indicated by error bars.
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IAPs, caspase processing is initiated, whether by the inducer
itself or by caspases released from IAP inhibition by inducer
competition for IAP binding.
In summary, we have found that D-IAP1, but not D-IAP2
or Op-IAP, inhibits apoptosis induced by active caspases of
dipteran, lepidopteran, and mammalian origin. D-IAP1 physi-
cally interacts with the active but not the zymogen form of
drICE suggesting that direct caspase inhibition is an evolutio-
narily conserved mechanism by which some IAPs can silence
cell death signaling. D-IAP1, D-IAP2, and Op-IAP block
HID-initiated processing of the drICE zymogen and this ac-
tivity correlates with their ability to interact with HID. We
propose a model in which the levels of IAPs relative to in-
ducers govern cell death.
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Fig. 4. The IAP apopstat model for regulating cell death. IAPs (tri-
angles) interact with pro-apoptotic inducers such as Reaper, HID,
Grim, and Doom (squares) and, in some cases, with caspases
(circles, zymogen form a closed circle, mature form a sectored
circle). When IAP levels exceed those of inducers and mature casp-
ases, the cell is relatively resistant to apoptotic signals and survives.
When inducer levels rise, IAPs are bound in complexes with in-
ducers, possibly releasing mature caspases from IAP inhibition. The
free, unbound inducers or mature caspases may further activate
zymogen processing, thereby triggering a caspase cascade resulting
in cell death.
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